• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FISHER & PAYKEL HEALTHCARE LTD OPTIFLOW + ADULT NASAL CANNULA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FISHER & PAYKEL HEALTHCARE LTD OPTIFLOW + ADULT NASAL CANNULA Back to Search Results
Lot Number NOT PROVIDED
Device Problem Connection Problem (2900)
Patient Problem Low Oxygen Saturation (2477)
Event Date 12/07/2023
Event Type  malfunction  
Event Description
A healthcare facility reported via a fisher & paykel healthcare (f&p) field representative that while using an f&p optiflow interface with an f&p mr850 humidifier and a nebulizer that the set up became disconnected.Information about where the disconnection occurred was not provided.It was also reported that the patient desaturated into the range of 50% spo2 at the time of the reported event.The patient was reported to have recovered from the event.F&p have requested for further details about the sequence of events including details of the device set up and where the disconnection occurred.
 
Manufacturer Narrative
B)(4).Fisher & paykel healthcare (f&p) is currently in the process of completing our investigation.We will provide a follow up report upon completion of our investigation.Optiflow + interfaces are designed for use with the airvo series humidifiers and are also compatible with the f&p mr850 and 950 humidification system devices.Optiflow + interfaces are intended for use with spontaneously breathing patients who would benefit from receiving high flow warmed and humidified respiratory gases.Optiflow + interfaces are not intended for life support and appropriate patient monitoring must be used at all times.
 
Manufacturer Narrative
(b)(4).The device details including the specific model number of the optiflow interface and circuit involved in the reported event were not provided.Optiflow + interfaces are designed for use with the airvo series humidifiers and are also compatible with the f&p mr850 and 950 humidification system devices.Optiflow + interfaces are intended for use with spontaneously breathing patients who would benefit from receiving high flow warmed and humidified respiratory gases.Optiflow + interfaces are not intended for life support and appropriate patient monitoring must be used at all times.Method: the complaint optiflow interface was not returned to f&p for evaluation.F&p requested for further details about the sequence of events including details of the device set up and where the disconnection occurred.The healthcare facility did not provide any further information despite f&p making several requests for this information.Our investigation is based on the initial information provided by the healthcare facility and our knowledge of the product.Results: the healthcare facility reported that there was a disconnection in the device setup of a nebulizer used with an optiflow interface and mr850 humidifier.Information on where the disconnection occurred was not provided.There was no reported damage.It was also reported that the patient desaturated into the range of 50% spo2 at the time of the reported event.The patient was reported to have recovered from the event.Conclusion: without further information about where the disconnection occurred, we are unable to determine the cause of the reported event.The user instructions which accompany the f&p optiflow interfaces show in pictorial format the correct placement and fitting of the device when used with an mr850 humidifier.The user instructions also state the following: "failure to use the set-up described can compromise performance and affect patient safety." "appropriate patient monitoring must be used at all times.Failure to monitor the patient may result in loss of therapy, serious injury or death.".
 
Event Description
A healthcare facility in (b)(6) reported via a fisher & paykel healthcare (f&p) field representative that while using an f&p optiflow interface with an f&p mr850 humidifier and a nebulizer that the set up became disconnected.Information about where the disconnection occurred was not provided.It was also reported that the patient desaturated into the range of 50% spo2 at the time of the reported event.The patient was reported to have recovered from the event.F&p requested for further details about the sequence of events including details of the device set up and where the disconnection occurred.The healthcare facility did not provide any further information despite f&p making several requests for this information.The device details including the specific model number of the optiflow interface and circuit involved in the reported event were not provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIFLOW + ADULT NASAL CANNULA
Type of Device
NASAL CANNULA
Manufacturer (Section D)
FISHER & PAYKEL HEALTHCARE LTD
15 maurice paykel place
east tamaki
auckland, 2013
NZ  2013
Manufacturer (Section G)
FISHER & PAYKEL HEALTHCARE LTD
15 maurice paykel place
east tamaki
auckland, 2013
NZ   2013
Manufacturer Contact
omid taheri
17400 laguna canyon road
suite 300
irvine, CA 92618
8007923912
MDR Report Key18378167
MDR Text Key331384216
Report Number9611451-2023-01223
Device Sequence Number1
Product Code BTT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K162553
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 12/07/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Lot NumberNOT PROVIDED
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/07/2023
Initial Date FDA Received12/21/2023
Supplement Dates Manufacturer Received02/22/2024
Supplement Dates FDA Received03/20/2024
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
F&P MR850 HUMIDIFIER; F&P MR850 HUMIDIFIER
-
-